Mayyda Asif Bajwa

Mayyda Asif Bajwa

Auto-generated profile, based on publicly available information

Mayyda Asif Bajwa

Faculty of Pharmacy, Forman Christine College University (FCCU) Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2021 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KAKanwal Ashiq
Kanwal Ashiq
MBMayyda Asif Bajwa
Mayyda Asif Bajwa
SASana Ashiq
Sana Ashiq

31 August 2020 in Journal of the Dow University of Health Sciences
Verified
Journal Article
Open access
MBMayyda Asif Bajwa
Mayyda Asif Bajwa
KAKanwal Ashiq
Kanwal Ashiq
The novel viral disease (COVID-19) with pneumonia like symptoms was first detected in Wuhan City of China, later reaching a status of the pandemic. The corona virus is now found affecting people all across the globe that in turn, threatens a great majority of people, both healthy and diseased. In particular, the population of patient is at high risk of being inflicted with infection.

20 December 2021 in SINDH UNIVERSITY RESEARCH JOURNAL -SCIENCE SERIES
Verified
Journal Article
Open access
PDF file
WIWajeeha Ishtiyaq
Wajeeha Ishtiyaq
ATArslan Tariq
Arslan Tariq
NANasir Abbas
Nasir Abbas
KAKanwal Ashiq
Kanwal Ashiq
MBMayyda Asif Bajwa
Mayyda Asif Bajwa
SASana Ashiq
Sana Ashiq
This study aims to develop, characterize and validate analytical method and perform stability studies of Racecadotril capsules to treat acute diarrhea. Six formulations of Racecadotril 100mg Capsules were prepared with different excipients by varying their concentrations. The HPLC method was validated on analytical parameters recommended by ICH Q2R guidelines, including specificity, accuracy and recovery, precision, quantitation limit, detection limit, range, linearity, and robustness. Forced degradation studies were performed as per the Stability Indicating Method under various stress conditions. Accelerated stability studies were performed on three stability batches of best fit formulation of Racecadotril 100mg Capsules as per ICH guidelines. Among the six formulations of Racecadotril 100mg Capsule, F6 was the best fit with a comparatively good dissolution profile with 76.9% release in 60 minutes. The HPLC system was suitable as % R.S.D. was 0.619147%, within the acceptance criteria. Furthermore, parameters including specificity, accuracy and recovery, precision, quantitation limit, detection limit, range, linearity, and robustness lie within the acceptance criteria. The percent degradation of Racecadotril after photolytic (sunlight for 6 hr.), oxidative (3% H2O2), acidic (0.1N HCl) and necessary (0.1N NaOH) stress was found to be 6.5%, 5.8%, 11.4%, and 28.4%, respectively. The product remains unchanged after thermal stress. HPLC method was successfully validated for Racecadotril 100mg Capsule as per ICH Q2R guidelines.

13 December 2025 in Next Research
Verified
Journal Article
Closed access
SSShumaila Shafique
Shumaila Shafique
ADAbdullah Dayo
Abdullah Dayo
UMUbed-Ur-Rehman Mughal
Ubed-Ur-Rehman Mughal
OMOmer Mustapha
Omer Mustapha
MBMayyda Asif Bajwa
Mayyda Asif Bajwa
AYAbid Yousaf
Abid Yousaf